by Clinical Neuropsychologist Online | Saturday, August 15, 2026 | Neurorehabilitation
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | August 15, 2026 Neuro-Rehab Previous Page
by Clinical Neuropsychologist Online | Friday, August 14, 2026 | Neuropsychology (general)
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | August 14, 2026 Neuro-General Previous Page
by Clinical Neuropsychologist Online | Friday, August 14, 2026 | Dementia
Overview of the study design and analytical workflow. Plasma samples from cognitively unimpaired (CU) participants were analyzed to evaluate progression to symptomatic Alzheimer’s disease (AD), and additional analyses examined progression from mild cognitive...
by Clinical Neuropsychologist Online | Friday, August 14, 2026 | Dementia
Abstract INTRODUCTION Amyloid-lowering antibodies are associated with neuroanatomical volume changes. This study aims to disentangle the contributions of amyloid-related imaging abnormalities (ARIA) and amyloid clearance to these changes. METHODS Data from the...
by Clinical Neuropsychologist Online | Friday, August 14, 2026 | Dementia
Abstract INTRODUCTION Astrocyte dysfunction is central to Alzheimer’s disease (AD), yet expression patterns of astrocytic markers remain poorly defined. We measured Aquaporin-4 (AQP4) and glial fibrillary acidic protein (GFAP) in post-mortem frontal cortex of AD...
